{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:37:08Z","timestamp":1771645028789,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T00:00:00Z","timestamp":1337212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Treatment effectiveness of <jats:italic>Helicobacter pylori<\/jats:italic> varies regionally and is decreasing worldwide, principally as a result of antibiotic resistant bacterium. Tetracycline is generally included in second line <jats:italic>H. pylori<\/jats:italic> eradication regimens. In Brazil, a high level of tetracycline resistance (TetR) is mainly associated with AGA926-928TTC 16\u2009S rDNA nucleotide substitutions. As <jats:italic>H. pylori<\/jats:italic> culture is fastidious, we investigated the primary occurrence of <jats:italic>H. pylori<\/jats:italic> 16\u2009S rDNA high level TetR genotype using a molecular approach directly on gastric biopsies of dyspeptic patients attending consecutively at Hospital das Clinicas of Marilia, S\u00e3o Paulo, Brazil.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Gastric biopsy specimens of 68 peptic ulcer disease (PUD) and 327 chronic gastritis (CG) patients with a positive histological diagnosis of <jats:italic>H. pylori<\/jats:italic> were investigated for TetR 16\u2009S rDNA genotype through a molecular assay based on amplification of a 16\u2009S rDNA 545\u2009bp fragment by polymerase chain reaction and H<jats:italic>infI<\/jats:italic> restriction fragment length polymorphism (PCR\/RFLP). Through this assay, AGA926-928TTC 16\u2009S rDNA TetR genotype resulted in a three DNA fragment restriction pattern (281, 227 and 37\u2009bp) and its absence originated two DNA fragments (264 and 281\u2009bp) due to a 16\u2009S rDNA conserved H<jats:italic>inf I<\/jats:italic> restriction site.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The 545\u2009bp 16\u2009S rDNA PCR fragment was amplified from 90% of gastric biopsies from histological <jats:italic>H. pylori<\/jats:italic> positive patients. H<jats:italic>infI<\/jats:italic> RFLP revealed absence of the AGA926\u2013928TTC <jats:italic>H. pylori<\/jats:italic> genotype and PCR products of two patients showed absence of the conserved 16\u2009S rDNA H<jats:italic>infI<\/jats:italic> restriction site. BLASTN sequence analysis of four amplicons (two conserved and two with an unpredicted H<jats:italic>infI<\/jats:italic> restriction pattern) revealed a 99% homology to <jats:italic>H. pylori<\/jats:italic> 16\u2009S rDNA from African, North and South American bacterial isolates. A nucleotide substitution abolished the conserved H<jats:italic>infI<\/jats:italic> restriction site in the two PCR fragments with unpredicted H<jats:italic>infI<\/jats:italic> RFLP, resulting in an E<jats:italic>coRI<\/jats:italic> restriction site.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n              <jats:italic>H. pylori<\/jats:italic> AGA926-928TTC 16\u2009S rDNA gene substitutions were not found in our population. More research is required to investigate if <jats:italic>H. pylori<\/jats:italic> TetR has a different genetic background in our region and if the nucleotide substitutions of the uncultured <jats:italic>H. pylori<\/jats:italic> 16\u2009S rRNA partial sequences have biological significance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-12-49","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T18:23:33Z","timestamp":1337279013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Absence of Helicobacter pylori high tetracycline resistant 16S rDNA AGA926-928TTC genotype in gastric biopsy specimens from dyspeptic patients of a city in the interior of S\u00e3o Paulo, Brazil"],"prefix":"10.1186","volume":"12","author":[{"given":"Rodrigo Buzinaro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane Maria","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Aparecida","family":"Speran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,17]]},"reference":[{"issue":"7\u20138","key":"769_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.lpm.2010.04.004","volume":"39","author":"F Megraud","year":"2010","unstructured":"Megraud F: Helicobacter pylori infection: review and practice. Presse Med. 2010, 39 (7\u20138): 815-822.","journal-title":"Presse Med"},{"issue":"2","key":"769_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrgastro.2010.210","volume":"8","author":"E Rimbara","year":"2011","unstructured":"Rimbara E, Fischbach LA, Graham DY: Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol. 2011, 8 (2): 79-88. 10.1038\/nrgastro.2010.210.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"769_CR3","first-page":"E3","volume":"12","author":"SA Chisholm","year":"2007","unstructured":"Chisholm SA, Teare EL, Davies K, Owen RJ: Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000\u20132005). Euro surveillance : bulletin europeen sur les maladies transmissibles. European communicable disease bulletin. 2007, 12 (7): E3-4.","journal-title":"European communicable disease bulletin"},{"issue":"2","key":"769_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/S0004-28032005000200012","volume":"42","author":"LG Coelho","year":"2005","unstructured":"Coelho LG, Zaterka S: Second brazilian consensus conference on helicobacter pylori infection. Arq Gastroenterol. 2005, 42 (2): 128-132.","journal-title":"Arq Gastroenterol"},{"issue":"6","key":"769_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1155\/2000\/604563","volume":"14","author":"D McNamara","year":"2000","unstructured":"McNamara D, O\u2019Morain C: Consensus guidelines: agreement and debate surrounding the optimal management of Helicobacter pylori infection. Canadian journal of gastroenterology. Journal canadien de gastroenterologie. 2000, 14 (6): 511-517.","journal-title":"Journal canadien de gastroenterologie"},{"issue":"6","key":"769_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/gut.2006.101634","volume":"56","author":"P Malfertheiner","year":"2007","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ: Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007, 56 (6): 772-781. 10.1136\/gut.2006.101634.","journal-title":"Gut"},{"issue":"8","key":"769_CR7","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","volume":"102","author":"WD Chey","year":"2007","unstructured":"Chey WD, Wong BC: American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007, 102 (8): 1808-1825. 10.1111\/j.1572-0241.2007.01393.x.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"769_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMc1006158","volume":"363","author":"DY Graham","year":"2010","unstructured":"Graham DY, Fischbach L: Helicobacter pylori infection. N Eng J Med. 2010, 363 (6): 595-596. author reply 596","journal-title":"N Eng J Med"},{"issue":"Suppl 1","key":"769_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1365-2036.2002.0160s1024.x","volume":"16","author":"A Qasim","year":"2002","unstructured":"Qasim A, O\u2019Morain CA: Review article: treatment of Helicobacter pylori infection and factors influencing eradication. Aliment Pharmacol Ther. 2002, 16 (Suppl 1): 24-30.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"769_CR10","first-page":"216","volume":"26","author":"J Wermeille","year":"2002","unstructured":"Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G, Buri P, Metry JM, Sitavanc R, Gallaz L, et al: Failure of Helicobacter pylori eradication: is poor compliance the main cause?. Gastroenterol Clin Biol. 2002, 26 (3): 216-219.","journal-title":"Gastroenterol Clin Biol"},{"issue":"Suppl 1","key":"769_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1523-5378.2008.00639.x","volume":"13","author":"BJ Egan","year":"2008","unstructured":"Egan BJ, Marzio L, O\u2019Connor H, O\u2019Morain C: Treatment of Helicobacter pylori infection. Helicobacter. 2008, 13 (Suppl 1): 35-40.","journal-title":"Helicobacter"},{"issue":"2","key":"769_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1590\/S0004-28032005000200009","volume":"42","author":"LC Frota","year":"2005","unstructured":"Frota LC, da Cunha Mdo P, Luz CR, de Araujo-Filho AH, Frota LA, Braga LL: Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial. Arq Gastroenterol. 2005, 42 (2): 111-115.","journal-title":"Arq Gastroenterol"},{"issue":"4","key":"769_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0213-005X(02)72778-X","volume":"20","author":"E Cuchi Burgos","year":"2002","unstructured":"Cuchi Burgos E, Forne Bardera M, Quintana Riera S, Lite Lite J, Garau Alemany J: [Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment]. Enferm Infecc Microbiol Clin. 2002, 20 (4): 157-160.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"9","key":"769_CR14","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1046\/j.1365-2036.2001.01068.x","volume":"15","author":"HK Parsons","year":"2001","unstructured":"Parsons HK, Carter MJ, Sanders DS, Winstanley T, Lobo AJ: Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther. 2001, 15 (9): 1473-1478. 10.1046\/j.1365-2036.2001.01068.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"769_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/jac\/47.4.459","volume":"47","author":"JJ Kim","year":"2001","unstructured":"Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FA, Osato MS, Graham DY, Kwon DH: Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001, 47 (4): 459-461. 10.1093\/jac\/47.4.459.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"769_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4067\/S0034-98872007000300002","volume":"135","author":"C Vallejos","year":"2007","unstructured":"Vallejos C, Garrido L, Caceres D, Madrid AM, Defilippi C, Toledo H: Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients. Rev Med Chil. 2007, 135 (3): 287-293.","journal-title":"Rev Med Chil"},{"issue":"2","key":"769_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1523-5378.2000.00011.x","volume":"5","author":"S Mendonca","year":"2000","unstructured":"Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, Pedrazzoli J: Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter. 2000, 5 (2): 79-83. 10.1046\/j.1523-5378.2000.00011.x.","journal-title":"Helicobacter"},{"issue":"1","key":"769_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/eri.09.113","volume":"8","author":"L Boyanova","year":"2010","unstructured":"Boyanova L, Mitov I: Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther. 2010, 8 (1): 59-70. 10.1586\/eri.09.113.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"769_CR19","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1128\/AAC.44.11.3203-3205.2000","volume":"44","author":"DH Kwon","year":"2000","unstructured":"Kwon DH, Kim JJ, Lee M, Yamaoka Y, Kato M, Osato MS, El-Zaatari FA, Graham DY: Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother. 2000, 44 (11): 3203-3205. 10.1128\/AAC.44.11.3203-3205.2000.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"769_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1046\/j.1523-5378.1999.99002.x","volume":"4","author":"G Realdi","year":"1999","unstructured":"Realdi G, Dore MP, Piana A, Atzei A, Carta M, Cugia L, Manca A, Are BM, Massarelli G, Mura I, et al: Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies. Helicobacter. 1999, 4 (2): 106-112. 10.1046\/j.1523-5378.1999.99002.x.","journal-title":"Helicobacter"},{"issue":"2","key":"769_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1128\/AAC.49.2.578-583.2005","volume":"49","author":"JY Wu","year":"2005","unstructured":"Wu JY, Kim JJ, Reddy R, Wang WM, Graham DY, Kwon DH: Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16\u2009S rRNA-encoding genes. Antimicrob Agents Chemother. 2005, 49 (2): 578-583. 10.1128\/AAC.49.2.578-583.2005.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"769_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1523-5378.2009.00654.x","volume":"14","author":"HY Woo","year":"2009","unstructured":"Woo HY, Park DI, Park H, Kim MK, Kim DH, Kim IS, Kim YJ: Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens. Helicobacter. 2009, 14 (1): 22-28. 10.1111\/j.1523-5378.2009.00654.x.","journal-title":"Helicobacter"},{"issue":"4","key":"769_CR23","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1128\/JCM.39.4.1217-1220.2001","volume":"39","author":"SA Chisholm","year":"2001","unstructured":"Chisholm SA, Owen RJ, Teare EL, Saverymuttu S: PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol. 2001, 39 (4): 1217-1220. 10.1128\/JCM.39.4.1217-1220.2001.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"769_CR24","first-page":"BR183","volume":"14","author":"S Tajbakhsh","year":"2008","unstructured":"Tajbakhsh S, Samarbaf-Zadeh AR, Moosavian M: Comparison of fluorescent in situ hybridization and histological method for the diagnosis of Helicobacter pylori in gastric biopsy samples. Medical science monitor: international medical journal of experimental and clinical research. 2008, 14 (9): BR183-BR187.","journal-title":"Medical science monitor: international medical journal of experimental and clinical research"},{"issue":"7","key":"769_CR25","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1128\/JCM.02352-07","volume":"46","author":"C Burucoa","year":"2008","unstructured":"Burucoa C, Garnier M, Silvain C, Fauchere JL: Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J Clin Microbiol. 2008, 46 (7): 2320-2326. 10.1128\/JCM.02352-07.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"769_CR26","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","volume":"103","author":"DE Brodersen","year":"2000","unstructured":"Brodersen DE, Clemons WM, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V: The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell. 2000, 103 (7): 1143-1154. 10.1016\/S0092-8674(00)00216-6.","journal-title":"Cell"},{"issue":"8","key":"769_CR27","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/emboj\/20.8.1829","volume":"20","author":"M Pioletti","year":"2001","unstructured":"Pioletti M, Schlunzen F, Harms J, Zarivach R, Gluhmann M, Avila H, Bashan A, Bartels H, Auerbach T, Jacobi C, et al: Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J. 2001, 20 (8): 1829-1839. 10.1093\/emboj\/20.8.1829.","journal-title":"EMBO J"},{"issue":"9","key":"769_CR28","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/AAC.46.9.2996-3000.2002","volume":"46","author":"MM Gerrits","year":"2002","unstructured":"Gerrits MM, de Zoete MR, Arents NL, Kuipers EJ, Kusters JG: 16\u2009S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2002, 46 (9): 2996-3000. 10.1128\/AAC.46.9.2996-3000.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"769_CR29","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1128\/JB.184.8.2131-2140.2002","volume":"184","author":"CA Trieber","year":"2002","unstructured":"Trieber CA, Taylor DE: Mutations in the 16\u2009S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol. 2002, 184 (8): 2131-2140. 10.1128\/JB.184.8.2131-2140.2002.","journal-title":"J Bacteriol"},{"issue":"9","key":"769_CR30","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1128\/AAC.47.9.2984-2986.2003","volume":"47","author":"MM Gerrits","year":"2003","unstructured":"Gerrits MM, Berning M, Van Vliet AH, Kuipers EJ, Kusters JG: Effects of 16\u2009S rRNA gene mutations on tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003, 47 (9): 2984-2986. 10.1128\/AAC.47.9.2984-2986.2003.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"769_CR31","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1128\/AAC.46.12.3940-3946.2002","volume":"46","author":"D Dailidiene","year":"2002","unstructured":"Dailidiene D, Bertoli MT, Miciuleviciene J, Mukhopadhyay AK, Dailide G, Pascasio MA, Kupcinskas L, Berg DE: Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16\u2009S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother. 2002, 46 (12): 3940-3946. 10.1128\/AAC.46.12.3940-3946.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"769_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0928-8244(03)00277-3","volume":"40","author":"ML Ribeiro","year":"2004","unstructured":"Ribeiro ML, Gerrits MM, Benvengo YH, Berning M, Godoy AP, Kuipers EJ, Mendonca S, van Vliet AH, Pedrazzoli J, Kusters JG: Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP. FEMS Immunol Med Microbiol. 2004, 40 (1): 57-61. 10.1016\/S0928-8244(03)00277-3.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"769_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1099\/0022-1317-49-5-415","volume":"49","author":"L Boyanova","year":"2000","unstructured":"Boyanova L, Stancheva I, Spassova Z, Katzarov N, Mitov I, Koumanova R: Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. J Med Microbiol. 2000, 49 (5): 415-418.","journal-title":"J Med Microbiol"},{"issue":"Suppl 1","key":"769_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1365-2036.11.s1.11.x","volume":"11","author":"F Megraud","year":"1997","unstructured":"Megraud F: Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther. 1997, 11 (Suppl 1): 43-53.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"769_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jac\/46.1.121","volume":"46","author":"H Wu","year":"2000","unstructured":"Wu H, Shi XD, Wang HT, Liu JX: Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin. J Antimicrob Chemother. 2000, 46 (1): 121-123. 10.1093\/jac\/46.1.121.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"769_CR36","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/jcp.42.7.727","volume":"42","author":"A Morris","year":"1989","unstructured":"Morris A, Ali MR, Brown P, Lane M, Patton K: Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol. 1989, 42 (7): 727-732. 10.1136\/jcp.42.7.727.","journal-title":"J Clin Pathol"},{"issue":"17","key":"769_CR37","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25 (17): 3389-3402. 10.1093\/nar\/25.17.3389.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"769_CR38","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/jcp.53.10.756","volume":"53","author":"O Rotimi","year":"2000","unstructured":"Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF: Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000, 53 (10): 756-759. 10.1136\/jcp.53.10.756.","journal-title":"J Clin Pathol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-12-49\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-49","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:50:00Z","timestamp":1630525800000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-12-49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,17]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-12-49","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,17]]},"assertion":[{"value":"5 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"49"}}